The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide & Liraglutide in Type 2 Diabetes Patients (TROPHIES): 12-month data analysis

Bruno Guerci,Francesco Giorgino,Luis-Emilio García-Pérez,Kristina Boye,Kirsi Norrbacka,Helene Sapin,Elke Heitmann,Jeremie Lebrec,Anne Dib,Marco Orsini Federici,Martin Füchtenbusch

Hand in Hand zum Ziel – einfach.besser.messbar www.diabeteskongress.deDiabetologie und Stoffwechsel（2022）

引用 0|浏览4

暂无评分

摘要

Background TROPHIES is a 24-month, prospective, non-comparative, observational study in adult patients with T2D initiating their first injectable glucose-lowering treatment with once-weekly dulaglutide (DU) or once-daily liraglutide (LIRA) in France, Germany, and Italy.

查看译文

关键词

diabetes patients,dulaglutide,health outcomes,liraglutide,real-world

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide &amp; Liraglutide in Type 2 Diabetes Patients (TROPHIES): 12-month data analysis

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide & Liraglutide in Type 2 Diabetes Patients (TROPHIES): 12-month data analysis